Thank you for Subscribing to CIO Applications Weekly Brief
Cardinal Health Introduces Navista TS to Help Oncology Practices Improve Patient Care, Lower Costs and Drive Success in Value-Based Care
CORE assists oncologists in proactively identifying patients that are at high risk of adverse effects or are on a fast track to being so.
FREMONT, CA: Cardinal Health Specialty Solutions has introduced Cardinal Health Navista Tech Solutions (TS), an advanced suite of technology solutions to empower community oncologists to improve outcomes and costs associated with patient treatment as they transition to value-based care.
"Community-based oncology practices are facing unprecedented pressure as they pivot to adapt to value-based reimbursement models," stated Heidi Hunter, President of Cardinal Health Specialty Solutions. "With Navista TS, we are delivering the most complete set of integrated, AI-enabled solutions and actionable insights to enable oncologists to improve patient care and enhance practice performance."
Navista TS consists of connected, point-of-service technology solutions including:
• Episode Analytics, a data-driven cost tracking tool, built by Cardinal Health's innovation engine, Fuse. This tool allows oncologists and administrators to accurately measure the cost of care at the start of and during the episode of care, enabling more informed treatment decisions as well as clearer insights into value-based performance.
• CureMD Oncology Cloud. The integrated platform includes electronic health records
(EHR), revenue cycle management services (RCM), a practice management system (PMS), a patient portal, and telehealth solutions. The platform assists in simplifying decision making, streamlining operations, and ensuring a smooth transition to value-based care, saving providers time as well as elevating administrative burden so they can focus on patient care. CureMD and Cardinal Health will work in partnership to provide CureMD's oncology tech solutions.
AI-enabled population health decision support, CORE, by Jvion. CORE assists oncologists in proactively identifying patients that are at high risk of adverse effects or are on a fast track to being so. The CORE identifies the health and social levers and approaches that can be used to reduce the number of expensive ER and hospital visits. Cardinal Health is the reseller of Jvion oncology products to community oncology practices.
• Clinical trials matching solution, VIPER, by Deep Lens. VIPER leverages AI to identify and match cancer patients to clinical trials, including precision medicine studies, faster as well as more efficiently. Cardinal Health and Deep Lens are working in collaboration to provide VIPER to community oncology practices.
Navista TS helps oncology practices consider the most important cost and value factors, recognize services that provide the highest-quality care at the lowest cost, and choose the best treatment plan at the start of treatment. It also aids in the automation of manual processes and the reduction of operating costs.